363 related articles for article (PubMed ID: 18625779)
1. In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.
da Silva CF; Batista MM; Batista Dda G; de Souza EM; da Silva PB; de Oliveira GM; Meuser AS; Shareef AR; Boykin DW; Soeiro Mde N
Antimicrob Agents Chemother; 2008 Sep; 52(9):3307-14. PubMed ID: 18625779
[TBL] [Abstract][Full Text] [Related]
2. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
[TBL] [Abstract][Full Text] [Related]
3. Cellular effects of reversed amidines on Trypanosoma cruzi.
Silva CF; Meuser MB; De Souza EM; Meirelles MN; Stephens CE; Som P; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2007 Nov; 51(11):3803-9. PubMed ID: 17698624
[TBL] [Abstract][Full Text] [Related]
4. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395
[TBL] [Abstract][Full Text] [Related]
5. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
6. Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.
Batista Dda G; Batista MM; de Oliveira GM; do Amaral PB; Lannes-Vieira J; Britto CC; Junqueira A; Lima MM; Romanha AJ; Sales Junior PA; Stephens CE; Boykin DW; Soeiro Mde N
Antimicrob Agents Chemother; 2010 Jul; 54(7):2940-52. PubMed ID: 20457822
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
[TBL] [Abstract][Full Text] [Related]
8. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
9. In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi.
Timm BL; Da Silva PB; Batista MM; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Parasitology; 2014 Sep; 141(10):1272-6. PubMed ID: 24735493
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi.
Ramírez-Macías I; Marín C; Chahboun R; Messouri I; Olmo F; Rosales MJ; Gutierrez-Sánchez R; Alvarez-Manzaneda E; Sánchez-Moreno M
Am J Trop Med Hyg; 2012 Sep; 87(3):481-8. PubMed ID: 22802442
[TBL] [Abstract][Full Text] [Related]
11. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
[TBL] [Abstract][Full Text] [Related]
12. Diamidine activity against trypanosomes: the state of the art.
Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.
Silva JJ; Osakabe AL; Pavanelli WR; Silva JS; Franco DW
Br J Pharmacol; 2007 Sep; 152(1):112-21. PubMed ID: 17603548
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
[TBL] [Abstract][Full Text] [Related]
15. Coumarins isolated from Calophyllum brasiliense produce ultrastructural alterations and affect in vitro infectivity of Trypanosoma cruzi.
Rodríguez-Hernández KD; Martínez I; Agredano-Moreno LT; Jiménez-García LF; Reyes-Chilpa R; Espinoza B
Phytomedicine; 2019 Aug; 61():152827. PubMed ID: 31039535
[TBL] [Abstract][Full Text] [Related]
16. Risedronate in the treatment of Murine Chagas' disease.
Bouzahzah B; Jelicks LA; Morris SA; Weiss LM; Tanowitz HB
Parasitol Res; 2005 Jun; 96(3):184-7. PubMed ID: 15844009
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
18. Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo.
de Souza EM; Oliveira GM; Boykin DW; Kumar A; Hu Q; De Nazaré C Soeiro M
J Antimicrob Chemother; 2006 Sep; 58(3):610-4. PubMed ID: 16854954
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.
Matsuo AL; Silva LS; Torrecilhas AC; Pascoalino BS; Ramos TC; Rodrigues EG; Schenkman S; Caires AC; Travassos LR
Antimicrob Agents Chemother; 2010 Aug; 54(8):3318-25. PubMed ID: 20479201
[TBL] [Abstract][Full Text] [Related]
20. Effects of astaxanthin in mice acutely infected with Trypanosoma cruzi.
Contreras-Ortiz JME; Barbabosa-Pliego A; Oros-Pantoja R; Aparicio-Burgos JE; Zepeda-Escobar JA; Hassan-Moustafa WH; Ochoa-García L; Uxúa Alonso-Fresan M; Tenorio Borroto E; Vázquez-Chagoyán JC
Parasite; 2017; 24():17. PubMed ID: 28560955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
